Biotest Aktiengesellschaft (BIO3) - Total Liabilities

Latest as of March 2025: €906.90 Million EUR ≈ $1.06 Billion USD

Based on the latest financial reports, Biotest Aktiengesellschaft (BIO3) has total liabilities worth €906.90 Million EUR (≈ $1.06 Billion USD) as of March 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Biotest Aktiengesellschaft (BIO3) long-term investment share to see how much of total assets are deployed in long-term investments.

Biotest Aktiengesellschaft - Total Liabilities Trend (2002–2024)

This chart illustrates how Biotest Aktiengesellschaft's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see how large is Biotest Aktiengesellschaft's balance sheet.

Biotest Aktiengesellschaft Competitors by Total Liabilities

The table below lists competitors of Biotest Aktiengesellschaft ranked by their total liabilities.

Company	Country	Total Liabilities
King-Strong New Material Technology Co Ltd SHE:300629	China	CN¥329.87 Million
Hunan Airbluer Environmental Protection Technology Co. Ltd. SHE:301259	China	CN¥611.23 Million
Ballard Power Systems Inc TO:BLDP	Canada	CA$103.64 Million
Liberty Broadband Srs A NASDAQ:LBRDA	USA	$1.94 Billion
Shanghai Kelai Mechatronics SHG:603960	China	CN¥123.23 Million
Chapters Group AG XETRA:CHG	Germany	€306.36 Million
ACNB Corporation NASDAQ:ACNB	USA	$2.90 Billion
Mengtian Home Group Inc. SHG:603216	China	CN¥384.28 Million

Liability Composition Analysis (2002–2024)

This chart breaks down Biotest Aktiengesellschaft's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See Biotest Aktiengesellschaft net asset quality index to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	4.93	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	1.78	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.64	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Biotest Aktiengesellschaft's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Biotest Aktiengesellschaft (2002–2024)

The table below shows the annual total liabilities of Biotest Aktiengesellschaft from 2002 to 2024.

Year	Total Liabilities	Change
2024-12-31	€903.30 Million ≈ $1.06 Billion	-0.95%
2023-12-31	€912.00 Million ≈ $1.07 Billion	+9.63%
2022-12-31	€831.90 Million ≈ $972.58 Million	+14.94%
2021-12-31	€723.80 Million ≈ $846.20 Million	+4.94%
2020-12-31	€689.70 Million ≈ $806.33 Million	+9.22%
2019-12-31	€631.50 Million ≈ $738.29 Million	+15.43%
2018-12-31	€547.10 Million ≈ $639.62 Million	-13.26%
2017-12-31	€630.70 Million ≈ $737.35 Million	+10.24%
2016-12-31	€572.10 Million ≈ $668.85 Million	+3.94%
2015-12-31	€550.40 Million ≈ $643.48 Million	-0.36%
2014-12-31	€552.40 Million ≈ $645.81 Million	+29.73%
2013-12-31	€425.80 Million ≈ $497.80 Million	+36.08%
2012-12-31	€312.91 Million ≈ $365.83 Million	-6.90%
2011-12-31	€336.09 Million ≈ $392.93 Million	+3.50%
2010-12-31	€324.73 Million ≈ $379.64 Million	-10.69%
2009-12-31	€363.59 Million ≈ $425.08 Million	+7.36%
2008-12-31	€338.67 Million ≈ $395.94 Million	+8.92%
2007-12-31	€310.94 Million ≈ $363.52 Million	+59.71%
2006-12-31	€194.69 Million ≈ $227.62 Million	-1.73%
2005-12-31	€198.12 Million ≈ $231.63 Million	-20.85%
2004-12-31	€250.31 Million ≈ $292.64 Million	+1.47%
2003-12-31	€246.69 Million ≈ $288.41 Million	-5.55%
2002-12-31	€261.20 Million ≈ $305.37 Million	--

About Biotest Aktiengesellschaft

XETRA:BIO3 Germany

Market Cap

$656.94 Million

€561.91 Million EUR

Market Cap Rank

#10969 Global

#1260 in Germany

Share Price

€28.40

Change (1 day)

+0.00%

52-Week Range

€28.40 - €28.40

All Time High

€43.69